Certified by Founder Lodge
Engrail Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $157,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meani
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 20 ,2024 | Series B | $157,000,000 |
Eight Roads
Red Tree Venture Capital
Forbion
RiverVest Venture Partners
Longwood Fund
Ysios Capital
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
XCENA | $135,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
